Tianjin Lisheng Pharmaceutical Co.,Ltd.
SZSE:002393.SZ
24.35 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,130.163 | 1,146.589 | 1,091.941 | 1,140.838 | 1,615.276 | 1,503.607 | 1,029.433 | 846.853 | 774.782 | 773.726 | 1,044.398 | 1,117.068 | 763.642 | 737.972 | 595.702 | 592.538 | 393.292 | 349.443 |
Cost of Revenue
| 495.622 | 486.28 | 454.481 | 439.505 | 447.758 | 427.121 | 378.746 | 365.428 | 346.505 | 347.123 | 369.382 | 428.415 | 299.496 | 295.386 | 218.285 | 241.409 | 119.926 | 105.902 |
Gross Profit
| 634.54 | 660.309 | 637.46 | 701.332 | 1,167.518 | 1,076.487 | 650.687 | 481.425 | 428.277 | 426.603 | 675.015 | 688.653 | 464.146 | 442.586 | 377.418 | 351.129 | 273.365 | 243.541 |
Gross Profit Ratio
| 0.561 | 0.576 | 0.584 | 0.615 | 0.723 | 0.716 | 0.632 | 0.568 | 0.553 | 0.551 | 0.646 | 0.616 | 0.608 | 0.6 | 0.634 | 0.593 | 0.695 | 0.697 |
Reseach & Development Expenses
| 96.465 | 105.977 | 104.087 | 76.7 | 123.429 | 94.298 | 102.19 | 64.212 | 33.226 | 41.492 | 39.289 | 40.624 | 25.49 | 23.308 | 17.631 | 17.307 | 12.982 | 0 |
General & Administrative Expenses
| 24.609 | 26.468 | 28.737 | 29 | 34.085 | 28.385 | 23.974 | 20.05 | 10.634 | 20.556 | 26.476 | 25.379 | 23.439 | 17.72 | 16.572 | 14.817 | 13.884 | 64.455 |
Selling & Marketing Expenses
| 318.94 | 336.017 | 362.914 | 424.416 | 692.31 | 660.393 | 307.954 | 193.373 | 173.28 | 195.802 | 228.42 | 216.156 | 114.054 | 96.987 | 84.837 | 86.801 | 64.442 | 67.199 |
SG&A
| 411.617 | 362.485 | 391.652 | 453.415 | 726.394 | 688.779 | 331.928 | 213.423 | 183.914 | 216.357 | 254.897 | 241.535 | 137.493 | 114.707 | 101.41 | 101.619 | 78.326 | 131.653 |
Other Expenses
| -13.833 | 108.388 | 96.111 | 113.141 | 121.702 | -1.022 | 0.2 | 1.998 | 2.039 | 4.413 | 5.456 | 5.251 | 0.89 | 3.573 | 6.388 | 0.256 | 1.004 | 0.691 |
Operating Expenses
| 521.915 | 576.85 | 591.85 | 643.256 | 971.525 | 903.134 | 552.364 | 366.206 | 299.839 | 338.344 | 370.169 | 366.775 | 222.257 | 199.643 | 165.431 | 162.745 | 118.475 | 136.522 |
Operating Income
| 112.625 | 175.672 | 136.908 | 102.355 | 220.148 | 215.011 | 130.626 | 131.285 | 133.624 | 107.781 | 347.969 | 357.988 | 386.006 | 261.517 | 195.275 | 172.369 | 154.738 | 117.251 |
Operating Income Ratio
| 0.1 | 0.153 | 0.125 | 0.09 | 0.136 | 0.143 | 0.127 | 0.155 | 0.172 | 0.139 | 0.333 | 0.32 | 0.505 | 0.354 | 0.328 | 0.291 | 0.393 | 0.336 |
Total Other Income Expenses Net
| 296.569 | -57.307 | 0.212 | -71.423 | -3.355 | 40.636 | 32.503 | 18.064 | 6.945 | 23.814 | 48.331 | 41.197 | 144.884 | 22.125 | -10.433 | -15.867 | 0.807 | 10.88 |
Income Before Tax
| 409.194 | 118.364 | 137.12 | 30.932 | 216.793 | 213.989 | 130.826 | 133.283 | 135.384 | 112.073 | 353.177 | 363.076 | 386.773 | 265.068 | 201.554 | 172.517 | 155.697 | 117.9 |
Income Before Tax Ratio
| 0.362 | 0.103 | 0.126 | 0.027 | 0.134 | 0.142 | 0.127 | 0.157 | 0.175 | 0.145 | 0.338 | 0.325 | 0.506 | 0.359 | 0.338 | 0.291 | 0.396 | 0.337 |
Income Tax Expense
| 58.386 | 24.758 | 15.015 | 22.317 | 28.656 | 29.012 | 14.009 | 17.677 | 21.167 | 19.187 | 55.115 | 61.333 | 53.382 | 45.806 | 35.303 | 29.059 | 23.744 | 18.968 |
Net Income
| 361.828 | 93.607 | 122.105 | 8.615 | 188.137 | 184.978 | 116.817 | 115.606 | 114.214 | 92.884 | 298.059 | 297.105 | 324.769 | 203.395 | 154.508 | 132.008 | 132.448 | 100.226 |
Net Income Ratio
| 0.32 | 0.082 | 0.112 | 0.008 | 0.116 | 0.123 | 0.113 | 0.137 | 0.147 | 0.12 | 0.285 | 0.266 | 0.425 | 0.276 | 0.259 | 0.223 | 0.337 | 0.287 |
EPS
| 1.97 | 0.51 | 0.67 | 0.047 | 1.03 | 1.01 | 0.64 | 0.63 | 0.63 | 0.51 | 1.61 | 1.63 | 1.9 | 1.22 | 1.13 | 0.97 | 0.97 | 0.73 |
EPS Diluted
| 1.97 | 0.51 | 0.67 | 0.047 | 1.03 | 1.01 | 0.64 | 0.63 | 0.63 | 0.51 | 1.61 | 1.63 | 1.9 | 1.22 | 1.13 | 0.97 | 0.97 | 0.73 |
EBITDA
| 179.93 | 241.793 | 212.709 | 165.834 | 304.416 | 282.549 | 195.072 | 207.989 | 172.574 | 143.962 | 379.023 | 391.319 | 406.118 | 284.351 | 225.02 | 200.878 | 168.756 | 104.885 |
EBITDA Ratio
| 0.159 | 0.211 | 0.195 | 0.145 | 0.188 | 0.188 | 0.189 | 0.246 | 0.223 | 0.186 | 0.363 | 0.35 | 0.532 | 0.385 | 0.378 | 0.339 | 0.429 | 0.3 |